Sidley Represented Eight Roads Ventures in Insilico Medicine's US$37 Million Series B Financing

Sidley represented Eight Roads Ventures as an investor in Insilico Medicine's US$37 million Series B funding round. Insilico Medicine is engaged in developing next-generation artificial intelligence technology for drug discovery. The financing round included Eight Roads Ventures, F-Prime Capital, Qiming Venture Partners, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital, Bold Capital Partners and other Series A investors.

The Sidley team was led by partner Ruchun Ji (Shanghai and Palo Alto) with assistance from associate Henry Cao (Shanghai).